Aug. 27, 2025 – The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical trials and science ...
Aug. 19, 2025 — Idorsia Ltd recently announced its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan ...
Aug. 27, 2025 — Royal Philips has released Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Aug. 25, 2025 — Amgen has announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of ...
Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...
Aug. 21, 2025 — Boston Scientific has initiated the AGENT DCB STANCE trial to assess the safety and effectiveness of the ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...
Aug. 19, 2025 — Openwater, an open-source medical technology company delivering portable, hospital-grade diagnostic and ...
Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Aug. 18, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...
Aug. 18, 2025 — iRhythm Technologies, Inc. has announced the publication of a real-world evidence study: Assessment of ...
Aug. 19, 2025 — In a move to advance stroke care and accelerate critical decision-making, Tift Regional Medical Center ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...
Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...
Aug. 13, 2025 — BioCardia, Inc., a provider of cellular and cell-derived therapeutics for treating cardiovascular and ...
August 28, 2025
